Carcinoma of the gallbladder

Lancet Oncology

Volumn 4, Issue 3, 2003, Pages 167-176

  Misra, Sanjeev ^a   Chaturvedi, Arun ^a   Misra, Naresh C ^b   Sharma, Indra D ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Lucknow Cancer Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; MITOMYCIN C; PACLITAXEL;

BILIARY TRACT TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CHILE; CHOLECYSTECTOMY; DISEASE COURSE; EXCISION; GALLBLADDER CARCINOMA; GALLSTONE; HUMAN; INDIA; INOPERABLE CANCER; JAPAN; LAPAROSCOPY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

EID: 0037340582     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01021-0     Document Type: Review

References (79)

1. Misra NC, Misra S, Chaturvedi A. Carcinoma gallbladder. In: Johnson CD, Taylor I (Eds). Recent advances in surgery, volume 20. London: Churchill Livingstone, 1997: 69-87.
2. Nagorney DM, McPherson GA. Carcinoma of the gallbladder and extrahepatic bile ducts. Semin Oncol 1988; 15: 106-15.
3. Piehler JM, Crichlow RW. Primary carcinoma of the gallbladder. Surg Gynaecol Obstet 1978; 146: 929-42.
4. Lazcano-Ponce EC, Miguel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51: 349-64.
5. Indian Council of Medical Research (ICMR). Annual report of population based cancer registries of the National Cancer Registry Programme (1993). New Delhi: ICMR Publication, 1996: 18.
6. Tominaga S, Kuroishi T, Ogawa H, Shimizu H. Epidemiologic aspects of biliary tract cancer in Japan. Natl Cancer Inst Monogr 1979; 53: 25-34.
7. Strom BL, Soloway RD, Rios-Dalenz JL et al. Risk factors for gallbladder cancer: an international collaborative case-control study. Cancer 1995; 76: 1747-56.
8. Diehl AK. Epidemiology of gallbladder cancer: a synthesis of recent data. J Natl Cancer Inst 1980; 65: 1209-14.
9. Zatonski WA, Lowenfels AB, Boyle P, et al. Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH program of the International Agency for Research on Cancer. J Natl Cancer Inst 1997; 89: 1132-38.
10. Misra NC, Chaturvedi A, Ahmad A, et al. Epidemiology, aetiology and chemotherapy of cancer gallbladder with special reference to intrahepatic arterial infusion with mitomycin-c (MMC) and 5-fluorouracil (5 FU). Proceedings ofthe 5th International Congress on Anti-Cancer Treatment, Paris 1995: 0-737, 162.
11. Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA 1983; 250: 2323-26.
12. Nervi F, Duarte I, Gomez G. et al. Frequency of gallbladder cancer in Chile. Int J Cancer 1988; 41: 657-60.
13. So CB, Gibney RG, Scudamore CH. Carcinoma of the gallbladder - a risk associated with gallbladder preserving treatments for cholelithiasis. Radiology 1990; 174: 127-30.
14. Albores-Saavedra J, Alcantra-Vazguez A, Cruz-Ortiz H, Herra-Goepfert R. The precursor lesions of invasive gallbladder carcinoma: hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980; 45: 919-27.
15. Towfigh S, McFadden DW, Cortina GR, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surgeon 2001; 67: 7-10.
16. Stephen AE, Berger DL. Carcinoma in the porcelain gallbladder: a relationship revisited. Surgery 2001; 129: 699-703.
17. Aldridge MC, Bismuth H. Gallbladder cancer: the polyp cancer sequence. Br J Surg 1990; 77: 363-64.
18. Chijiiwa K, Kimura H, Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction. Int Surg 1995; 80: 61-64.
19. Kowalewski K, Todd EF. Carcinoma of the gallbladder induced in hamsters by insertion of cholesterol pellets and feeding dimethylnitrosamine. Proc Soc Exp Biol Med 1971; 136: 482-86.
20. Hai AA, Sinha DN, Shah SC, et al. Carcinoma gallbladder - possible aetiology. In: Rao RS, Deo MG, Sanghvi LD, (Eds). Proceedings of the XVI International Cancer Congress. Monduzzi Editore, 1994; 2069-72.
21. Shukla VK, Tiwari SC, Roy SK. Biliary bile acids in cholelithiasis and carcinoma of the gall bladder. Eur J Cancer Prev 1993; 2: 155-60.
22. Shukla VK, Shukla PK, Pandey M, et al. Lipid peroxidation product in bile from patients with carcinoma of the gallbladder: a preliminary study. J Surg Oncol 1994; 56: 258-62.
23. Pandey M, Shukla VK. Fatty acids, biliary bile acids, lipid peroxidation products and gallbladder carcinogenesis. Eur J Cancer Prev 2000; 9: 165-71.
24. Dutta U, Garg PK, Kumar R, Tandon RK. Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder. Am J Gastroenterol 2000; 95: 784-87.
25. Csendes A, Becerra M, Burdiles P, et al. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstone disease. Eur J Surg 1994; 160: 363-67.
26. Roa I, Araya JC, Villaseca M, et al. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology 1996; 111: 232-36.
27. Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 1999; 30: 21-25.
28. Sumiyoshi K, Nagai E, Chijiiwa K, Nakayama F. Pathology of carcinoma of the gallbladder. World J Surg 1991; 15: 315-21.
29. Albores-Saavedra J, Henson DE, Sobin LH. The WHO histological classification of tumours of the gallbladder and extrahepatic bile duct. A commentary on the second edition. Cancer 1992; 70: 410-14.
30. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer 1992; 70: 1493-97.
31. Misra S, Chaturvedi A, Goel MM, et al. Overexpression of p53 protein in gallbladder carcinoma in North India. Eur J Surg Oncol 2000; 26: 164-67.
32. Fahim RB, McDonald JR, Richards JC, Ferris DO. Carcinoma of the gallbladder: a study of its modes of spread. Ann Surg 1962; 156: 114-24.
33. Muratore A, Polastri R, Capussotti L. Radical surgery for gallbladder cancer: current options. Eur J Surg Oncol 2000; 26: 438-43.
34. Ouchi K, Owada Y, Matsumo S, Sato T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery 1987; 101: 731-37.
35. Misra NC,Misra S, Chaturvedi A. Epidemiology, etiology and new persepective in carcinoma gallbladder. Indian J Surg 1998; 60: 167-75.
36. Hederstrom E, Forsberg L. Ultrasonography in carcinoma of the gallbladder: diagnostic difficulties and pitfalls. Acta Radiol 1987; 28: 715-21.
37. Chijiiwa K, Sumiyoshi K, Nakayama F. Impact of recent advances in hepatobiliary imaging techniques on the preoperative diagnosis of carcinoma of the gallbladder. World J Surg 1991; 15: 332-37.
38. Bach AM, Loring LA, Hann LE, et al. Gallbladder cancer: can ultrasonography evaluate extent of disease? J Ultrasound Med 1998; 17: 303-09.
39. Ueno N, Tomiyama T, Tano S, et al. Diagnosis of gallbladder carcinoma with color doppler ultrasonography. Am J Gastroenterol 1996; 91: 1647-49.
40. Azuma T, Yoshikawa T, Araida T, Takasaki K. Differential diagnosis of polypoid lesions of the gallbladder by endoscopic ultrasonography. Am J Surg 2001; 181: 65-70.
41. Kumar A, Aggarwal S. Carcinoma of the gallbladder: CT finding in 50 cases. Abdom Imaging 1994; 19: 304-08.
42. Kersting-Sommerhoff B, Helmberger H, Bauth W. Radiologic diagnosis and staging of gallbladder and bile duct tumours. Endoscopy 1993; 25: 86-91.
43. Schwartz LH, Coakley FV, Sun Y, et al. Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangio-pancreatography. Am J Roentgenol 1998; 170: 1491-95.
44. Akosa AB, Barker F, Desa L, et al. Cytologic diagnosis in the management of gallbladder carcinoma Acta Cytol 1995; 39: 494-98.
45. Strom BL, Maislin G, West SL, et al. Serum CEA and CA 19-9: potential future diagnostic or screening tests for gallbladder cancer? Int J Cancer 1990; 45: 821-24.
46. Ritts RE Jr, Nagorney DM, Jacobsen DJ, et al. Comparison of preoperative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic or gallbladder disease. Pancreas 1994; 9: 707-16.
47. Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder, staging, treatment and prognosis. Cancer 1976; 37: 141-48.
48. Sobin LH, Wittekind Ch. Digestive system: gallbladder. In: Sobin LH, Witterkind CH (Eds). TNM classification of malignant tumours, 5th edn. New York: Wiley Liss, 1997; 78-80.
49. Sobin LH, Wittekind Ch. Digestive system: gallbladder. In: TNM classification of malignant tumours, 6th edn. New York: Wiley - Liss, 2002; 84-86.
50. Gall FP, Kockerling F, Scheels J, et al. Radical operations for carcinoma of the gallbladder: present in Germany. World J Surg 1991; 15: 328-36.
51. Ouchi K, Suzuki M, Tominaga T, et al. Survival after surgery for cancer of the gallbladder. Br J Surg 1994; 81: 1655-57.
52. Fong Y, Heffernan N, Blumgart LH. Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial. Cancer 1998; 83: 423-27.
53. Shirai Y, Yoshida K, Tsukada K, Muto T. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 1992; 215: 326-31.
54. Bartlett DL. Gallbladder cancer. Semin Surg Oncol 2000; 19: 145-55.
55. Torterolo E, Aizen B, Silva C, et al. An approach to histologically diagnosed gallbladder carcinoma following cholecystectomy for presumed benign disease. J Surg Oncol Suppl 1993; 3: 175-78.
56. Yoshikawa T, Araida T, Azuma T, Takasaki K. Bisubsegmental liver resection for gallbladder cancer. Hepatogastroenterology 1998; 45: 14-19.
57. Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 1996; 224: 639-46.
58. De Aretxabala X, Roa IS, Burgos LA, et al. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 1997; 163: 419-26.
59. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000; 232: 557-69.
60. Yamaguchi K, Tsuneyoshi M. Subclinical gallbladder carcinoma. Am J Surg 1992; 163: 382-86.
61. Misra NC, Misra S, Chaturvedi A, et al. Epidemiology, aetiology and multimodal therapy in cancer gallbladder with special reference to radical surgery and newer chemotherapy protocols: A prospective study of 631 patients. Proceedings of the American Society of Clinical Oncology Pan Asia Cancer conference, New Delhi, India. 2002: 85-87.
62. de-Aretxabala X, Roå I, Burges L, et al. Gallbladder cancer in Chile: a report on 54 potentially resectable tumours. Cancer 1992; 69: 60-65.
63. Wakai T, Shirai Y, Yokoyama N, et al. Early gallbladder carcinoma does not warrant radical resection. Br J Surg 2001; 88: 675-78.
64. Suzuki K, Kimura T, Ogawa H. Is laparoscopic cholecystectomy hazardous for gallbladder cancer? Surgery 1998; 123: 311-14.
65. Onoyama H, Yamamoto M, Tseng A, et al. Extended cholecystectomy for carcinoma of the gallbladder. World J Surg 1995; 19: 758-63.
66. Ogura Y, Mizumoto R, Isaji S, et al. Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg 1991; 15: 337-43.
67. Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg 1992; 163: 239-45.
68. Donohue JH, Nagorney DM, Grant CS, et al. Carcinoma of the gallbladder- does radical resection improve outcome. Arch Surg 1990; 125: 237-41.
69. Nimura Y, Hayakawa N, Kamiya J, et al. Hepato-pancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology 1991; 38: 170-75.
70. Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of gallbladder. Surgery 1989; 106: 467-72.
71. Kondo S, Nimura Y, Hayakawa N, et al. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 2000; 87: 418-22.
72. Blumgart LH, Thompson JN. The management of malignant strictures of the bile duct. Curr Probl Surg 1987; 24: 69-127.
73. Houry S, Haccart V, Huguier M, Schlienger M. Gallbladder cancer: role of radiation therapy. Hepatogastroenterology 1999; 46: 1578-84.
74. Todoroki T, Iwaski Y, Orii K, et al. Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg 1991; 15: 357-66.
75. Kresl JJ, Schild SE, Henning GT, et al. Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 2002; 52: 167-75.
76. Todoroki T. Chemotherapy for gallbladder carcinoma - a surgeon's perspective. Hepatogastroentology 2000; 47: 948-55.
77. Misra NC, Chaturvedi A, Jaiswal MSD, et al. Intrahepatic arterial infusion with combination of mitomycin c (MMC) and 5-fluorouracil (5-FU) for treatment of primary and metastatic carcinoma liver. Reg Cancer Treat 1992; 5: 12-16.
78. Misra NC, Jaiswal MSD, Singh RV, Das B. Intrahepatic arterial infusion with combination mitomycin-c and 5-fluorouracil for treatment of primary and metastatic carcinoma liver. Cancer 1977; 39: 1425-29.
79. Misra S, Misra NC, Sharma ID, et al. Newer Chemotherapy protocols in advanced cancer gallbladder. Proceedings of the XVth Asia Pacific Cancer Conference, Chennai 1999; 12-15, 94.